Back
Stoke Therapeutics Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
27
STOK
Stoke Therapeutics
Last Price:
12.63
Seasonality Move:
11.82%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- The current trend is relatively stagnant and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Stoke Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.35 | Buy |
| 20-day SMA: | 12.22 | Buy |
| 50-day SMA: | 13.42 | Sell |
| 200-day SMA: | 11.64 | Buy |
| 8-day EMA: | 12.29 | Buy |
| 20-day EMA: | 12.47 | Sell |
| 50-day EMA: | 13.05 | Sell |
| 200-day EMA: | 11.97 | Buy |
Stoke Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 46.75 | Sell |
| Chaikin Money Flow: | 72908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.83 - 12.71) | Buy |
| Bollinger Bands (100): | (12.66 - 15.14) | Sell |
Stoke Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 12.38 while STOK 8-day simple moving average is 12.35, which is a Buy signal.
- The stock price of STOK is 12.38 while Stoke Therapeutics 20-day SMA is 12.22, which makes it a Buy.
- Stoke Therapeutics 50-day simple moving average is 13.42 while STOK share price is 12.38, making it a Sell technically.
- STOK stock price is 12.38 and Stoke Therapeutics 200-day simple moving average is 11.64, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
27
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a Sell
The current Stoke Therapeutics [STOK] share price is $12.38. The Score for STOK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
651.78M
Price in USD:
12.38
Share Volume:
116.11K
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
3.46
Sell
27
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?
The Stoke Therapeutics stock price is 12.38 USD today. -
Will STOK stock go up or go down?
Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Stoke Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 12.38 while STOK 8-day exponential moving average is 12.29, which is a Buy signal.
- The stock price of STOK is 12.38 while Stoke Therapeutics 20-day EMA is 12.47, which makes it a Sell.
- Stoke Therapeutics 50-day exponential moving average is 13.05 while STOK share price is 12.38, making it a Sell technically.
- STOK stock price is 12.38 and Stoke Therapeutics 200-day simple moving average is 11.97, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
- STOK Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Stoke Therapeutics is a Sell
- Stoke Therapeutics Relative Strength Index (RSI) is 46.75, which suggest Stoke Therapeutics is oversold
- The Bollinger Bands (25) for Stoke Therapeutics is (11.83 - 12.71), which suggest Stoke Therapeutics is a Sell
- The Bollinger Bands (100) for Stoke Therapeutics is (12.66 - 15.14), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.